Aromatase inhibitor-induced joint pain: Melatonin's role

Medical Hypotheses

Volumn 71, Issue 6, 2008, Pages 862-867

  Burk, R ^a  

^a Burk Labs   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN; MELATONIN; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; TAMOXIFEN; VITAMIN D;

ANAMNESIS; ARTHRALGIA; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; HORMONE ACTION; HUMAN; LIGHT EMITTING DIODE; MORNING STIFFNESS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

AROMATASE INHIBITORS; ARTHRALGIA; ARTHRITIS, RHEUMATOID; CIRCADIAN RHYTHM; ESTROGENS; HUMANS; LONGITUDINAL STUDIES; MELATONIN; MODELS, BIOLOGICAL;

EID: 53949106529     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.07.040     Document Type: Article

References (27)

1. Ohsako T., Inoue K., Nagamoto N., Yoshida Y., Nakahara O., and Sakamoto N. Joint symptoms: a practical problem of anastrozole. Breast Cancer 13 3 (2006) 284-288
2. Morales L., Pans S., Paridaens R., et al. Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging. Breast Cancer Res Treat 104 1 (2007) 87-91
3. Burstein H.J., and Winer E.P. Aromatase inhibitors and arthralgias: a new frontier in symptom management for breast cancer survivors. J Clin Oncol 25 25 (2007) 3797-3799
4. Crew K.D., Greenlee H., Capodice J., Raptis G., Brafman L., Fuentes D., et al. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol 25 25 (2007) 3877-3883
5. Partridge A.H., LaFountain A., Mayer E., Taylor B.S., Winer E., and Asnis-Alibozek A. Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 26 4 (2008) 556-562
6. Loprinzi C.L., Duffy J., and Ingle J.N. Postchemotherapy rheumatism. J Clin Oncol 11 4 (1993) 768-770
7. Smith D.E. Additional cases of postchemotherapy rheumatism. J Clin Oncol 11 8 (1993) 1625-1626
8. Michl I., and Zielinski C.C. More postchemotherapy rheumatism. J Clin Oncol 11 10 (1993) 2051-2052
9. Felson D.T., and Cummings S.R. Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis Rheum 52 9 (2005) 2594-2598
10. Brainard G.C., Hanifin J.P., Greeson J.M., Byrne B., Glickman G., Gerner E., et al. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci 21 16 (2001) 6405-6412
11. Thapan K., Arendt J., and Skene D.J. An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans. J Physiol 535 Pt 1 (2001) 261-267
12. Figueiro M.G., Bullough J.D., Parsons R.H., and Rea M.S. Preliminary evidence for spectral opponency in the suppression of melatonin by light in humans. Neuroreport 15 2 (2004) 313-316
13. Revell V.L., and Skene D.J. Light-induced melatonin suppression in humans with polychromatic and monochromatic light. Chronobiol Int 24 6 (2007) 1125-1137
14. Szczepanik M. Melatonin and its influence on immune system. J Physiol Pharmacol 58 Suppl. 6 (2007) 115-124
15. Sulli A., Maestroni G.J., Villaggio B., Hertens E., Craviotto C., Pizzorni C., et al. Melatonin serum levels in rheumatoid arthritis. Ann N Y Acad Sci 966 (2002) 276-283
16. Okatani Y., Morioka N., and Wakatsuki A. Changes in nocturnal melatonin secretion in perimenopausal women: correlation with endogenous estrogen concentrations. J Pineal Res 28 2 (2000) 111-118
17. Hayashi K., and Okatani Y. Mechanisms underlying the effects of estrogen on nocturnal melatonin synthesis in peripubertal female rats: relation to norepinephrine and adenylate cyclase. J Pineal Res 26 3 (1999) 178-183
18. Cascio C., Russo D., Drago G., Galizzi G., Passantino R., Guarneri R., et al. 17beta-estradiol synthesis in the adult male rat retina. Exp Eye Res 85 1 (2007) 166-172
19. Perras B., Meier M., and Dodt C. Light and darkness fail to regulate melatonin release in critically ill humans. Intensive Care Med 33 11 (2007) 1954-1958
20. Rupp T.L., Acebo C., and Carskadon M.A. Evening alcohol suppresses salivary melatonin in young adults. Chronobiol Int 24 3 (2007) 463-470
21. Aoki H., Ozeki Y., and Yamada N. Hypersensitivity of melatonin suppression in response to light in patients with delayed sleep phase syndrome. Chronobiol Int 18 2 (2001) 263-271
22. Higuchi S., Motohashi Y., Ishibashi K., and Maeda T. Influence of eye colors of Caucasians and Asians on suppression of melatonin secretion by light. Am J Physiol Regul Integr Comp Physiol 292 6 (2007) R2352-R2356
23. Jasser S.A., Hanifin J.P., Rollag M.D., and Brainard G.C. Dim light adaptation attenuates acute melatonin suppression in humans. J Biol Rhythm 21 5 (2006) 394-404
24. Higuchi S., Motohashi Y., Maeda T., and Ishibashi K. Relationship between individual difference in melatonin suppression by light and habitual bedtime. J Physiol Anthropol Appl Human Sci 24 4 (2005) 419-423
25. Smitten A.L., Simon T.A., Hochberg M.C., and Suissa S. A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther 10 2 (2008) R45
26. Morel B., Marotte H., and Miossec P. Will steroidal aromatase inhibitors induce rheumatoid arthritis?. Comment Arthritis Rheum 54 4 (2006) 1355-1356
27. Herljevic M., Middleton B., Thapan K., and Skene D.J. Light-induced melatonin suppression: age-related reduction in response to short wavelength light. Exp Gerontol 40 3 (2005) 237-242